Enthera is a clinical-stage biopharmaceutical company founded in 2016 and headquartered in Milan, Italy. The company focuses on developing first-in-class therapeutics for auto-immune disorders and is backed by investors such as Sofinnova Partners and BiovelocITA.
Subscribe to see Enthera’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Enthera is a biotechnology company headquartered in Italy. It has raised at least $33M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Series A, closed in January 2021. Xcout tracks 5 named people at Enthera, including Lisa Maria Olson, PhD (Chief Executive Officer/Director).
At least $33M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | Undisclosed | 8 named | |
| Series A | $33M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.